Lexaria Bioscience Warrant
LEXXW
LEXXW was delisted on the 13th of January, 2026.
3 hedge funds and large institutions have $97 invested in Lexaria Bioscience Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
6.89% more ownership
Funds ownership: 5.16% → 12.06% (+6.9%)
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
97% less capital invested
Capital invested by funds: $3.5K → $97 (-$3.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$3.32K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$809 |
| 3 |
CS
Clear Street
New York
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
-$3.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$194 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $96 | +$809 | +22,919 | New |
|
|
CS
2
Clear Street
New York
| $1 | +$4 | +100 | +100% |
|
|
HCM
3
Heights Capital Management
San Francisco,
California
| – | -$3.3K | -41,251 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$194 | -2,424 | Closed |
|
|
HF
5
HRT Financial
New York
| – | +$3.32K | +94,177 | +832% |
|
LEXXW Hedge Fund Activity: Q4 2025 in Review
3 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q4 2025, worth a combined $97 — down 97% from $3.5K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LEXXW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was HRT Financial, adding an estimated $3.32K. The largest seller was Heights Capital Management, exiting entirely with an estimated $3.3K sold.
- 3 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q4 2025, down from 4 in Q3 2025.
- Funds reported $97 of Lexaria Bioscience Warrant stock for Q4 2025, down 97% quarter-over-quarter.
- 1 fund opened new Lexaria Bioscience Warrant positions in Q4 2025 and 2 closed out, a net change of -1 holder.
- The largest Lexaria Bioscience Warrant buyer in Q4 2025 was HRT Financial, an estimated $3.32K added.
- The largest Lexaria Bioscience Warrant seller in Q4 2025 was Heights Capital Management, an estimated $3.3K sold.
Based on aggregated 13F filings for Q4 2025.